BostonGene IPO

bostongene.com

BostonGene is a biotechnology company focused on healthcare's transition to personalized medicine using AI-based molecular and immune profiling to improve the standard of care, accelerate research, and improve economics.

Founded2015
Total Funding to Date$200MM
Register for Details

For more details on financing and valuation for BostonGene, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

BostonGene Ticker Symbol

BostonGene does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

BostonGene Stock Price

The stock price for BostonGene will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

BostonGene Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
4/6/2022 Series B $2.05B $XXX.XX $XXX.XX
4/24/2019 Series A $333.33MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like BostonGene in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM